Key facts
- It has raised $4.0M across 2 recorded rounds; the latest was Seed Round ($2.2M) in Feb 2026.
- Notable investors include Capital Q Ventures, Cor Medical Ventures.
- Meduloc has filed 1 Form D with the SEC, most recently Mar 2024 ($1.8M sold to 10 investors).
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Meduloc
Funding rounds
2 roundsAbout Meduloc
Developer of an intramedullary fixation device designed to assist doctors in fixing small and long-bone fractures. The company's device provides the surgeon with superior fracture reduction and fixation control along with rotational stability, as it utilizes a minimally invasive, soft tissue-sparing surgical approach, enabling medical professionals to treat mid-shaft small bone fractures of the metacarpal, metatarsal, phalange, clavicle, and fibula.
- Sector
- Healthcare
- HQ
- Del Mar, CA, United States
- Founded
- 2016
- Website
- meduloc.com/
- Ownership
- Privately Held (backing)
Meduloc doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Meduloc shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Meduloc in its N-PORT filings yet. We sweep new filings monthly.